Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer-Reference-Cited by-同舟云学术

Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer

Published:2012-07 Issue:1 Volume:77 Page:89-96
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Wang Luhua,Wu Shixiu,Ou Guangfei,Bi Nan,Li Wenfeng,Ren Hua,Cao Jianzhong,Liang Jun,Li Junling,Zhou Zongmei,Lv Jima,Zhang Xiangru

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference26 articles.

1. American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

2. Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410;Curran;J Natl Cancer Inst,2011

3. Third-generation chemotherapy agents in the treatment of advanced non-small cell lung cancer: a meta-analysis;Baggstrom;J Thorac Oncol,2007

4. Concurrent cisplatin, etoposide, and chest radiotherapy in pathologic sage IIIB no-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019;Albain;J Clin Oncol,2001

5. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06;Lee;J Clin Oncol,1996

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evans syndrome suggests disease progression in lung adenocarcinoma;Respiratory Medicine Case Reports;2024

2. Comparison of post-chemoradiotherapy pneumonitis between Asian and non-Asian patients with locally advanced non-small cell lung cancer: a systematic review and meta-analysis;eClinicalMedicine;2023-10

3. Ipsilateral lung dose as a correlative measure for radiation pneumonitis in patients treated with definitive concurrent radiochemotherapy;Journal of Cancer Research and Therapeutics;2023

4. Consolidation Systemic Therapy in Locally Advanced, Inoperable Nonsmall Cell Lung Cancer—How to Identify Patients Which Can Benefit from It?;Current Oncology;2022-10-31

5. Three-week Cycles of Paclitaxel-Carboplatin Administered Concurrently with Radiotherapy for Inoperable Stage III Non-small Cell Lung Cancer: 10-Year Single-Centre Experience;Hong Kong Journal of Radiology;2022-09-26